Status:
COMPLETED
Medication Management and Culture of Safety
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Cardiovascular Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There will be no significant decrease in the use of low dose acetylsalicylic acid (ASA) therapy for primary prevention across the three intervention arms from baseline to completion of the project. T...
Detailed Description
We will assess the current use of aspirin therapy for primary and secondary cardiovascular disease prevention in six general internal medicine and family medicine clinics within the University of Colo...
Eligibility Criteria
Inclusion
- All patient on low-dose aspirin without an appropriate diagnosis of coronary artery disease or thrombotic stroke/transient ischemic attack (TIA) within the six practices.
Exclusion
- Persons not on aspirin therapy or persons on aspirin therapy for reasons other than prevention of cardiovascular disease (i.e., pain relief) will not be included in the study.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
7000 Patients enrolled
Trial Details
Trial ID
NCT01247454
Start Date
July 1 2009
End Date
September 1 2010
Last Update
April 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Clinics
Denver, Colorado, United States, 80045